Cargando…

Safety of atorvastatin in Asian patients within clinical trials

INTRODUCTION: Data on statin safety in Asian patients are limited compared with evidence from Western populations. AIM: This study assessed atorvastatin safety among Asian patients enrolled in 58 randomized clinical trials. METHODS: Data from 52 short‐term trials (median exposure 4–72 weeks) and six...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Juliana C. N., Kong, Alice P. S., Bao, Weihang, Fayyad, Rana, Laskey, Rachel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129583/ https://www.ncbi.nlm.nih.gov/pubmed/27520479 http://dx.doi.org/10.1111/1755-5922.12214

Ejemplares similares

An Eight-Week Trial Investigating the Efficacy and Tolerability of Atorvastatin for Children and Adolescents With Heterozygous Familial Hypercholesterolemia
por: Gandelman, Kuan, et al.
Publicado: (2011)

Comparing the Safety and Efficacy of Celecoxib for the Treatment of Osteoarthritis in Asian and non-Asian Populations: An Analysis of Data from Two Randomized, Double-blind, Placebo-controlled, Active-comparator Trials
por: Lubis, Andri, et al.
Publicado: (2017)

Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial
por: Deedwania, Prakash C., et al.
Publicado: (2015)

Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial
por: Soedamah-Muthu, Sabita S., et al.
Publicado: (2015)

Efficacy and Safety of Atorvastatin in South Asian Patients with Dyslipidemia: An Open Label Noncomparative Pilot Study
por: Patel, Jeetesh V, et al.
Publicado: (2005)

Relationship of High‐Density Lipoprotein Cholesterol With Renal Function in Patients Treated With Atorvastatin
por: Ong, Kwok Leung, et al.
Publicado: (2018)

Efficacy and safety of nonsteroidal anti‐inflammatory drugs in Asian patients with knee osteoarthritis: summary of a randomized, placebo‐controlled study
por: Essex, Margaret N., et al.
Publicado: (2015)

Atorvastatin Has a Dose‐Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double‐Blind Randomized Controlled Trials
por: Vogt, Liffert, et al.
Publicado: (2019)

Efficacy and Safety of Linagliptin in 2681 Asian Patients Stratified by Age, Obesity, and Renal Function: A Pooled Analysis of Randomized Clinical Trials
por: Ning, Guang, et al.
Publicado: (2017)

Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS)
por: Livingstone, Shona J., et al.
Publicado: (2015)

Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial
por: Kimura, Genjiro, et al.
Publicado: (2016)

Tolerability and effectiveness of every-other-day atorvastatin compared to daily atorvastatin in patients with muscle symptoms: A randomized controlled clinical trial
por: Wijekoon, Nirmala, et al.
Publicado: (2020)

Atorvastatin Induced Erythrocytes Membrane Blebbing
por: Rana, Rumaisa Bashir, et al.
Publicado: (2019)

The Safety of Substitution of Antiretroviral Regimen in Non-Clinical Trial Settings in Asian Countries
por: Jung, In Young, et al.
Publicado: (2017)

Atorvastatin for Prevention of Amikacin-induced Electrolytes Imbalances; a Randomized Clinical Trial
por: Heydari, Behrooz, et al.
Publicado: (2016)

Statin therapy and hepatotoxicity: Appraisal of the safety profile of atorvastatin in hyperlipidemic patients
por: Kalantari, Saeed, et al.
Publicado: (2014)

Surface stabilized atorvastatin nanocrystals with improved bioavailability, safety and antihyperlipidemic potential
por: Sharma, Manu, et al.
Publicado: (2019)

Effect of atorvastatin in patients with chronic heart failure – insights from randomized clinical trials
por: Xu, Minwen, et al.
Publicado: (2010)

Evaluation of Atorvastatin for the Treatment of Patients With Asthma: A Double-Blind Randomized Clinical Trial
por: Moini, Abdollatif, et al.
Publicado: (2012)

Effects of Atorvastatin on Negative Sign in Chronic Schizophrenia: a Double Blind Clinical Trial
por: Sayyah, Mehdi, et al.
Publicado: (2015)

Atorvastatin Rapidly Reduces Hepatitis B Viral Load in Combination with Tenofovir: A Prospective Clinical Trial
por: Gharehbeglou, M., et al.
Publicado: (2022)

Atorvastatin-induced pancreatitis
por: Prajapati, Samir, et al.
Publicado: (2010)

Atorvastatin (Lipitor) by MCR
por: Zarganes-Tzitzikas, Tryfon, et al.
Publicado: (2019)

A clinical randomized trial on the use of atorvastatin in patients with sepsis or septic shock: effects on endothelial function
por: Prado, K, et al.
Publicado: (2013)

Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients
por: Barakat, Lolwa, et al.
Publicado: (2013)

Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial
por: Kronborg, Thit M., et al.
Publicado: (2023)

Combination therapy of atorvastatin and probucol on ischemic stroke in clinic
por: Yan, Tao, et al.
Publicado: (2012)

A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia
por: Kim, Ji Bak, et al.
Publicado: (2021)

Metabolic Alterations Associated with Atorvastatin/Fenofibric Acid Combination in Patients with Atherogenic Dyslipidaemia: A Randomized Trial for Comparison with Escalated-Dose Atorvastatin
por: Han, Ji Soo, et al.
Publicado: (2018)

A comparative evaluation of safety and efficacy of rosuvastatin, simvastatin, and atorvastatin in patients of type 2 diabetes mellitus with dyslipidemia
por: Adsule, Samir Maruti, et al.
Publicado: (2009)

Evaluation of the Anti-inflammatory Effects of Atorvastatin on Patients with Rheumatoid Arthritis: A Randomized Clinical Trial
por: Sarabi, Zhaleh Shariati, et al.
Publicado: (2016)

Impact of treatment with rosuvastatin and atorvastatin on cardiovascular outcomes: evidence from the Archimedes-simulated clinical trials
por: Colivicchi, Furio, et al.
Publicado: (2015)

Spectroscopic studies on photodegradation of atorvastatin calcium
por: Oprica, Madalina, et al.
Publicado: (2021)

Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia
por: Kim, Ji Bak, et al.
Publicado: (2021)

Heterogeneity within the Asian American community
por: Sadler, Georgia Robins, et al.
Publicado: (2003)

Efficacy and safety of Zhibitai in combination with atorvastatin for lipid lowering in patients with coronary heart disease
por: Xu, Danyan, et al.
Publicado: (2017)

Meta-Analysis of the Efficacy and Safety of Alendronate Combined with Atorvastatin in the Treatment of Osteoporosis in Diabetes Mellitus
por: Xiong, Zhencheng, et al.
Publicado: (2022)

Evaluation of the clinical efficacy of 1.2% atorvastatin in the treatment of periodontal intraosseous defects by CBCT: A randomized controlled clinical trial
por: Shirke, Prerna Y., et al.
Publicado: (2019)

Atorvastatin-induced acute pancreatitis
por: Deshpande, Prasanna R., et al.
Publicado: (2011)

Bioenhancing effects of naringin on atorvastatin
por: Sama, Venkatesh, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vmupkdinq02a3faoc2sgdaj8nq